Today Opyl Ltd announced the signing of a partnership with NeuroEndocrine Cancer Australia with the goal of creating greater awareness about Neuroendocrine cancer and access to clinical trials. We are really looking forward to tapping into the Opin platform and the possibilities it will provide. The future looks bright.
To read more about this announcement click here.
Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.
Friday 27th October we held our first ever NET Patient forum in Launceston Tasmania. NET patients travelled from Tasmania wide to here their local NET
This month the Manning River Times ran a featured article for NeuroEndocrine Cancer Australia titled, 25,550 Australians and counting: the growing need for neuroendocrine cancer
NECA launches its first National Awareness Campaign We are thrilled to have launched the National Awareness Campaign this month, with thanks to the Department of Health for
Senator, Wendy Askew has moved a motion to conduct a Senate Inquiry regarding Equitable Access to diagnosis and treatment for individuals with rare and less
Over 3,355 Healthcare Professionals Australia-wide have now enrolled in the free online, RACGP-approved Education Modules. Ask your GP to enrol today.
